Insight Molecular Diagnostics Inc.
IMDX· Nasdaq
IMDXInsight Molecular Diagnostics Inc.
Filed Apr 12, 2023 · 10-K · 102 days after period end · 0001493152-23-012005
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $274.00K | $3.59M | $503.00K | — |
| Net Income | -$44.98M | -$35.89M | -$6.31M | -$7.95M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Apr 12, 2023 · 102 d after period end
